Literature DB >> 17369907

Antidepressant activity of beta-lactam antibiotics and their effects on the severity of serotonin edema.

I A Volchegorskii1, E A Trenina.   

Abstract

Injection of beta-lactam antibiotics (reterpen, ceftazidime, and thienam) to mice in doses equivalent to the mean therapeutic doses for humans led to shortening of the duration of behavioral despair in the hanging by the tail test, modified the resistance to serotonin edema, and intensified the exploratory and orientation activity in the open field test. This sum of effects was detected after 10 injections of retarpen and thienam and after single and five-fold administration of ceftazidime. Antidepressant sertraline also shortened the duration of behavioral despair and reduced serotonin edema. An inverse correlation between the duration of behavioral despair and severity of serotonin edema was detected in control mice. The results suggest that beta-lactam antibiotics are characterized by antidepressant effect related to changes in serotonin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17369907     DOI: 10.1007/s10517-006-0295-9

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  Stereocontrolled access to δ-lactone-fused-γ-lactams bearing angular benzylic quaternary stereocenters.

Authors:  Timothy K Beng; Morgan J Rodriguez; Claire Borg
Journal:  RSC Adv       Date:  2022-06-14       Impact factor: 4.036

2.  Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties.

Authors:  Bruk Getachew; Joseph I Aubee; Richard S Schottenfeld; Antonei B Csoka; Karl M Thompson; Yousef Tizabi
Journal:  BMC Microbiol       Date:  2018-12-22       Impact factor: 3.605

3.  Exploring the chemical space and the bioactivity profile of lactams: a chemoinformatic study.

Authors:  Fernanda I Saldívar-González; Elena Lenci; Andrea Trabocchi; José L Medina-Franco
Journal:  RSC Adv       Date:  2019-08-28       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.